January 25, 2023 345 Treatment with amlitelimab—a novel non-depleting, non-cytotoxic anti-OX40Ligand monoclonal antibody—reduces IL-22 serum levels in a phase 2a randomized, placebo-controlled trial in patients with moderate-to-severe atopic dermatitis
August 2, 2022 Development of novel ultra-sensitive IL-11 target engagement assays to support mechanistic PK/PD modeling for an anti-IL-11 antibody therapeutic
March 15, 2022 The effect of transdermal gender-affirming hormone therapy on markers of inflammation and hemostasis
January 4, 2022 HLA alleles and sustained peanut consumption promote IgG4 responses in subjects protected from peanut allergy
December 2, 2021 Implanted pluripotent stem-cell-derived pancreatic endoderm cells secrete glucose-responsive C-peptide in patients with type 1 diabetes
November 12, 2021 Clinical improvement of ocular surface parameters in dry eye patients following treatment with urea/crosslinked-hyaluronate eyedrops correlates with the secretion of MUC-4
October 7, 2021 High Level of Inflammatory Cytokines in the Tears: A Bridge of Patients with Concomitant Exotropia and Dry Eye
September 15, 2021 Essential role of IL-23 in the development of acute exacerbation of pulmonary fibrosis